Multiple intracellular components

The term Multiple intracellular components is a non-specific designation used in pharmacological databases, such as ChEMBL, to categorize drugs that do not interact with a single, well-defined molecular target (ChEMBL, 2024). Instead, these agents often affect a variety of cellular structures, including nucleic acids, organelles, or a broad array of enzymes and proteins. This classification is frequently applied to traditional cytotoxic chemotherapeutics, such as alkylating agents or certain intercalating dyes, which disrupt cellular function through multiple pathways simultaneously (PubChem, 2024). Because this term does not refer to a specific biological entity or a single protein, it is generally considered an incorrect or placeholder target in the context of modern drug discovery and precision medicine. Understanding the specific molecular interactions of drugs labeled under this category is crucial for predicting efficacy and managing the systemic toxicity often associated with such broad-spectrum mechanisms (National Cancer Institute, 2023).

Other names

Intracellular componentsNon-specific intracellular targetsMultiple targets

Drugs associated with this term typically exert their effects through broad, non-specific interactions with various intracellular molecules, such as DNA intercalation, alkylation of nucleic acids, or inhibition of multiple enzymatic pathways simultaneously.